Adjuvant Endocrine Therapy with Cyclin-Dependent Kinase 4/6 Inhibitor, Ribociclib, for Localized Hormone Receptor-Positive/her2– Breast Cancer (LEADER)
npj Breast Cancer（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined